Moreover, ladostigil (TV3326), a propargylamine derivative and MAO‐A and MAO‐B inhibitor, is promising as a neuroprotective agent and is used in managing AD and PD (Xu et al., 2018). The gene discussed is MAOB; the disease is Alzheimer disease.